TXMD vs. BFRG, NEPH, EKSO, AXDX, BCTX, UBX, CPIX, ITRM, OCX, and LSTA
Should you be buying TherapeuticsMD stock or one of its competitors? The main competitors of TherapeuticsMD include Bullfrog AI (BFRG), Nephros (NEPH), Ekso Bionics (EKSO), Accelerate Diagnostics (AXDX), BriaCell Therapeutics (BCTX), Unity Biotechnology (UBX), Cumberland Pharmaceuticals (CPIX), Iterum Therapeutics (ITRM), OncoCyte (OCX), and Lisata Therapeutics (LSTA). These companies are all part of the "medical" sector.
TherapeuticsMD (NASDAQ:TXMD) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations.
TherapeuticsMD received 386 more outperform votes than Bullfrog AI when rated by MarketBeat users.
In the previous week, TherapeuticsMD had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 3 mentions for TherapeuticsMD and 2 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.87 beat TherapeuticsMD's score of 1.25 indicating that Bullfrog AI is being referred to more favorably in the news media.
Bullfrog AI has lower revenue, but higher earnings than TherapeuticsMD.
30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 1.2% of TherapeuticsMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
TherapeuticsMD's return on equity of -21.15% beat Bullfrog AI's return on equity.
TherapeuticsMD has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.
Summary
TherapeuticsMD beats Bullfrog AI on 8 of the 11 factors compared between the two stocks.
Get TherapeuticsMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TherapeuticsMD Competitors List
Related Companies and Tools
